KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Current Deferred Revenue (2019 - 2025)

Teladoc Health (TDOC) has disclosed Current Deferred Revenue for 7 consecutive years, with $71.4 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 9.9% to $71.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $71.4 million through Dec 2025, down 9.9% year-over-year, with the annual reading at $71.4 million for FY2025, 9.9% down from the prior year.
  • Current Deferred Revenue hit $71.4 million in Q4 2025 for Teladoc Health, down from $81.4 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $121.6 million in Q2 2023 to a low of $71.4 million in Q4 2025.
  • Historically, Current Deferred Revenue has averaged $96.1 million across 5 years, with a median of $100.4 million in 2021.
  • Biggest five-year swings in Current Deferred Revenue: skyrocketed 94.83% in 2021 and later plummeted 36.39% in 2025.
  • Year by year, Current Deferred Revenue stood at $102.0 million in 2021, then rose by 11.55% to $113.8 million in 2022, then dropped by 3.96% to $109.3 million in 2023, then decreased by 27.44% to $79.3 million in 2024, then dropped by 9.9% to $71.4 million in 2025.
  • Business Quant data shows Current Deferred Revenue for TDOC at $71.4 million in Q4 2025, $81.4 million in Q3 2025, and $85.4 million in Q2 2025.